{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:08:02Z","timestamp":1770142082006,"version":"3.49.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:00:00Z","timestamp":1224547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peripartum cardiomyopathy (PPCM) is a potentially devastating cause of heart failure that affects women late in pregnancy or in early puerperium. Recent findings showed that a 16 kDa fragment of prolactin may induce myocardial damage, and this offered a new option of treating PPCM by blocking prolactin with bromocriptine. We report on a 35-year-old woman with a twin gravidity who gave birth to two healthy boys at day 36\/6 and developed a potentially fatal PPCM. Within 3 days since delivery she suffered from severe symptoms of heart failure (orthopnoea, pleural and pericardial effusion, reduced systolic function LVEF 15%). Bromocriptine 2.5 mg bid was added to standard heart failure therapy at day 6 after delivery, and within a week the patient recovered to NYHA functional class II. 2 months later she presented in a good state, NYHA class I, and MRI confirmed an LVEF of 60%. Balancing the potential side effects of bromocriptine against the very poor prognosis in severe PPCM our case supports the use of bromocriptine as a specific novel therapy.<\/jats:p>","DOI":"10.1016\/j.ejheart.2008.09.001","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T05:35:34Z","timestamp":1224135334000},"page":"1149-1151","source":"Crossref","is-referenced-by-count":33,"title":["Recovery from Peripartum Cardiomyopathy After Treatment With Bromocriptine"],"prefix":"10.1093","volume":"10","author":[{"given":"Dirk","family":"Habedank","sequence":"first","affiliation":[{"name":"Department of Cardiology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"York","family":"K\u00fchnle","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Elgeti","sequence":"additional","affiliation":[{"name":"Department of Radiology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9-Mitte , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim W.","family":"Dudenhausen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Haverkamp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Dietz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"issue":"2","key":"2026020203411483100_ejhf2008-09-001-bib-0001","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","article-title":"Incidence, mortality, and racial differences in peripartum cardiomyopathy","volume":"100","author":"Brar","year":"2007","journal-title":"Am J Cardiol"},{"issue":"16","key":"2026020203411483100_ejhf2008-09-001-bib-0002","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","article-title":"Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation","volume":"111","author":"Elkayam","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"2026020203411483100_ejhf2008-09-001-bib-0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijgo.2007.11.007","article-title":"Predictors of prognosis in patients with peripartum cardiomyopathy","volume":"101","author":"Duran","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2026020203411483100_ejhf2008-09-001-bib-0004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"issue":"24","key":"2026020203411483100_ejhf2008-09-001-bib-0005","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2007.10.006","article-title":"Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine","volume":"50","author":"Hilfiker-Kleiner","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ejheart.2008.09.001","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/10\/11\/1149\/66563698\/eurjhf_10_11_1149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/10\/11\/1149\/66563698\/eurjhf_10_11_1149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:41:23Z","timestamp":1770021683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/10\/11\/1149\/8439800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,21]]},"references-count":5,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,10,21]]},"published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ejheart.2008.09.001","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,11]]},"published":{"date-parts":[[2008,10,21]]}}}